MontalescotGSechtemUAchenbachSet al.2013 ESC Guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J2013; 34: 2949–3003.
2.
LockhartPBBolgerAFPapapanouPNet al.Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation2012; 125: 2520–2544.
3.
EberhardJGroteKLuchtefeldMet al.Experimental gingivitis induces systemic inflammatory markers in young healthy individuals: a single-subject interventional study. PloS One2013; 8: e55265–e55265.
HaverichA. A surgeon’s view on the pathogenesis of atherosclerosis. Circulation2017; 135: 205–207.
6.
O’ConnorCMDunneMWPfefferMAet al.Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. JAMA2003; 290: 1459–1466.
7.
RidkerPMEverettBMThurenTet al.Anti-inflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med2017; 377: 1119–1131.
8.
BattyGDJungKJMokYet al.Oral health and later coronary heart disease: cohort study of one million people. Eur J Prev Cardiol2018. 598–605.
9.
JeeSHSametJMOhrrHet al.Smoking and cancer risk in Korean men and women. Cancer Causes Control: CCC2004; 15: 341–348.
10.
ParkCGuallarELintonJAet al.Fasting glucose level and the risk of incident atherosclerotic cardiovascular diseases. Diabetes Care2013; 36: 1988–1993.
11.
EberhardJStieschMKerlingAet al.Moderate and severe periodontitis are independent risk factors associated with low cardiorespiratory fitness in sedentary non-smoking men aged between 45 and 65 years. J Clin Periodontol2014; 41: 31–37.
12.
MelkATegtburUHilfiker-KleinerDet al.Improvement of biological age by physical activity. Int J Cardiol2014; 176: 1187–1189.
